NR 503 Week 5: Infectious Disease Paper Discussion
NR 503 Week 5: Infectious Disease Paper Discussion
NR 503 Week 5: Infectious Disease Paper Discussion
Mycobacterium tuberculosis
Description of tuberculosis
Tuberculosis (TB) is a contagious, life-threatening infectious disease that primarily affects the lungs and is caused by the mycobacterium germ (Delogu, Sali, and Fadda, 2013). NR 503 Week 5: Infectious Disease Paper Discussion. General symptoms are a wracking cough, extreme weakness and fatigue, coughing up blood or phlegm (sputum), marked weight loss, fever and chills, profuse sweating, and severe chest pain while breathing or coughing (CDC: Signs and symptoms, 2016). A skin test or TB blood test are used to determine if a person has tuberculosis NR 503 Week 5: Infectious Disease Paper Discussion.
ORDER A PLAGIARISM-FREE PAPER HERE
The TB mode of transmission occurs when a person with TB coughs, sneezes, speaks, or opens his or her mouth; mycobacterium germs are released into the air and remain for hours— even days (CDC: How TB spreads, 2016). Complications of pulmonary TB include structural, metabolic, vascular, and infectious conditions (Shah & Reed, 2014). An acute complication of TB is sepsis (Shah & Reed, 2014). Chronic complications are pulmonary mycetoma or focal neurologic deficits from tuberculomas; pulmonary complications include hemoptysis (coughing up blood) or pneumothorax (collapsed lung) (Shah & Reed, 2014). TB is treated with or more first-line drugs for 6 to 12 months: isoniazid (INH), rifampin (RIF), ethambutol (EMB), and/or pyrazinamide (PZA) (CDC: Treatment for TB disease, 2016). If the strain of TB is resistant to first-line drugs, second-line group 2 drugs are given (CDC: Treatment for TB disease, 2016). Other TB drugs are categorized as second-line groups 3 and 4, and third-line group 5. The vaccine for TB is Bacille Calmette–Guèrin (BCG) (CDC: Treatment for TB disease, 2016). NR 503 Week 5: Infectious Disease Paper Discussion.
The NR 503 Week 5: Infectious Disease Paper Discussion assignment will follow the late assignment policy specified in the course syllabus.
NR 503 Week 5: Infectious Disease Paper Discussion
Criteria | Ratings | Pts | |||||
---|---|---|---|---|---|---|---|
Introduction of Communicable Disease NR 503 Week 5: Infectious Disease Paper Discussion |
|
||||||
Determinants of Health |
|
||||||
Host Factors |
|
||||||
Role of FNP |
|
||||||
APA Format / Writing Mechanics |
|